Yesterday, the Food and Drug Administration approved a new ALS treatment from Amylyx Pharmaceuticals Inc., despite its own assessment that the evidence the drug works is too thin.
#people #necessarily #legislation #family-members #investments #health-care #clinical-trials #pharmaceuticals #early-access #health-policy
[
add
]
[
|
|
...
]